Journal articleGastroenterology2026
Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer.
- Journal
- Gastroenterology
- Published
- 25 May 2026
- Citations
- 2
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 8
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Targets, Modulators and Delivery Program P30CA036727↗
- Rac1 GTPase in tumorigenesis and progression of pancreatic cancer R01CA206444↗
- Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia R01CA210637↗
- Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer R01CA247471↗
- Targeting LIF/LIFR in pancreatic cancer R44CA235991↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗
- Pancreatic Cancer Detection Consortium U01CA210240↗